nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.129	0.15	CbGbCtD
Rivaroxaban—ABCB1—Methylprednisolone—ankylosing spondylitis	0.11	0.129	CbGbCtD
Rivaroxaban—ABCB1—Betamethasone—ankylosing spondylitis	0.0718	0.084	CbGbCtD
Rivaroxaban—ABCB1—Prednisolone—ankylosing spondylitis	0.0708	0.0829	CbGbCtD
Rivaroxaban—ABCB1—Prednisone—ankylosing spondylitis	0.0669	0.0783	CbGbCtD
Rivaroxaban—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0662	0.0774	CbGbCtD
Rivaroxaban—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0642	0.0751	CbGbCtD
Rivaroxaban—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0501	0.0587	CbGbCtD
Rivaroxaban—CYP3A4—Betamethasone—ankylosing spondylitis	0.043	0.0503	CbGbCtD
Rivaroxaban—CYP3A4—Prednisolone—ankylosing spondylitis	0.0424	0.0496	CbGbCtD
Rivaroxaban—ABCB1—Dexamethasone—ankylosing spondylitis	0.0418	0.0489	CbGbCtD
Rivaroxaban—CYP3A4—Prednisone—ankylosing spondylitis	0.0401	0.0469	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—ankylosing spondylitis	0.0336	0.0393	CbGbCtD
Rivaroxaban—CYP3A4—Dexamethasone—ankylosing spondylitis	0.025	0.0293	CbGbCtD
Rivaroxaban—Infestation—Methylprednisolone—ankylosing spondylitis	0.000658	0.00453	CcSEcCtD
Rivaroxaban—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000658	0.00453	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000647	0.00446	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000643	0.00443	CcSEcCtD
Rivaroxaban—Epistaxis—Triamcinolone—ankylosing spondylitis	0.000622	0.00428	CcSEcCtD
Rivaroxaban—Renal failure acute—Methotrexate—ankylosing spondylitis	0.000612	0.00422	CcSEcCtD
Rivaroxaban—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000595	0.0041	CcSEcCtD
Rivaroxaban—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000593	0.00409	CcSEcCtD
Rivaroxaban—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000592	0.00408	CcSEcCtD
Rivaroxaban—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00059	0.00407	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00058	0.004	CcSEcCtD
Rivaroxaban—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000565	0.00389	CcSEcCtD
Rivaroxaban—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000552	0.0038	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000548	0.00378	CcSEcCtD
Rivaroxaban—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00054	0.00372	CcSEcCtD
Rivaroxaban—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00054	0.00372	CcSEcCtD
Rivaroxaban—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000537	0.0037	CcSEcCtD
Rivaroxaban—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000537	0.0037	CcSEcCtD
Rivaroxaban—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000536	0.00369	CcSEcCtD
Rivaroxaban—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000533	0.00367	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000532	0.00367	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00052	0.00358	CcSEcCtD
Rivaroxaban—Angioedema—Prednisolone—ankylosing spondylitis	0.000512	0.00353	CcSEcCtD
Rivaroxaban—Malaise—Prednisolone—ankylosing spondylitis	0.000505	0.00348	CcSEcCtD
Rivaroxaban—Syncope—Prednisolone—ankylosing spondylitis	0.000502	0.00346	CcSEcCtD
Rivaroxaban—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000502	0.00346	CcSEcCtD
Rivaroxaban—Eye disorder—Betamethasone—ankylosing spondylitis	0.000502	0.00346	CcSEcCtD
Rivaroxaban—Back pain—Triamcinolone—ankylosing spondylitis	0.000498	0.00343	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000492	0.00339	CcSEcCtD
Rivaroxaban—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000487	0.00336	CcSEcCtD
Rivaroxaban—Angiopathy—Betamethasone—ankylosing spondylitis	0.000487	0.00336	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000478	0.00329	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000477	0.00329	CcSEcCtD
Rivaroxaban—Discomfort—Prednisolone—ankylosing spondylitis	0.000471	0.00325	CcSEcCtD
Rivaroxaban—Angioedema—Triamcinolone—ankylosing spondylitis	0.000471	0.00324	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisone—ankylosing spondylitis	0.00047	0.00324	CcSEcCtD
Rivaroxaban—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00047	0.00324	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisone—ankylosing spondylitis	0.000468	0.00322	CcSEcCtD
Rivaroxaban—Malaise—Triamcinolone—ankylosing spondylitis	0.000464	0.0032	CcSEcCtD
Rivaroxaban—Malaise—Methylprednisolone—ankylosing spondylitis	0.000463	0.00319	CcSEcCtD
Rivaroxaban—Syncope—Triamcinolone—ankylosing spondylitis	0.000462	0.00318	CcSEcCtD
Rivaroxaban—Syncope—Methylprednisolone—ankylosing spondylitis	0.000461	0.00318	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000459	0.00317	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000457	0.00315	CcSEcCtD
Rivaroxaban—Oedema—Prednisolone—ankylosing spondylitis	0.000457	0.00315	CcSEcCtD
Rivaroxaban—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000453	0.00312	CcSEcCtD
Rivaroxaban—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000452	0.00311	CcSEcCtD
Rivaroxaban—Shock—Prednisolone—ankylosing spondylitis	0.00045	0.0031	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisolone—ankylosing spondylitis	0.000446	0.00307	CcSEcCtD
Rivaroxaban—Eye disorder—Prednisone—ankylosing spondylitis	0.000437	0.00301	CcSEcCtD
Rivaroxaban—Infestation—Methotrexate—ankylosing spondylitis	0.000435	0.003	CcSEcCtD
Rivaroxaban—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000435	0.003	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000435	0.00299	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000434	0.00299	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000434	0.00299	CcSEcCtD
Rivaroxaban—Discomfort—Triamcinolone—ankylosing spondylitis	0.000433	0.00299	CcSEcCtD
Rivaroxaban—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000432	0.00298	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000432	0.00297	CcSEcCtD
Rivaroxaban—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000429	0.00296	CcSEcCtD
Rivaroxaban—Renal failure—Methotrexate—ankylosing spondylitis	0.000428	0.00295	CcSEcCtD
Rivaroxaban—Angioedema—Betamethasone—ankylosing spondylitis	0.000427	0.00294	CcSEcCtD
Rivaroxaban—Angioedema—Dexamethasone—ankylosing spondylitis	0.000427	0.00294	CcSEcCtD
Rivaroxaban—Angiopathy—Prednisone—ankylosing spondylitis	0.000424	0.00292	CcSEcCtD
Rivaroxaban—Immune system disorder—Prednisone—ankylosing spondylitis	0.000422	0.00291	CcSEcCtD
Rivaroxaban—Malaise—Dexamethasone—ankylosing spondylitis	0.000421	0.0029	CcSEcCtD
Rivaroxaban—Malaise—Betamethasone—ankylosing spondylitis	0.000421	0.0029	CcSEcCtD
Rivaroxaban—Oedema—Triamcinolone—ankylosing spondylitis	0.00042	0.0029	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00042	0.0029	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000419	0.00289	CcSEcCtD
Rivaroxaban—Syncope—Dexamethasone—ankylosing spondylitis	0.000419	0.00289	CcSEcCtD
Rivaroxaban—Syncope—Betamethasone—ankylosing spondylitis	0.000419	0.00289	CcSEcCtD
Rivaroxaban—Infection—Triamcinolone—ankylosing spondylitis	0.000418	0.00288	CcSEcCtD
Rivaroxaban—Infection—Methylprednisolone—ankylosing spondylitis	0.000417	0.00287	CcSEcCtD
Rivaroxaban—Haematuria—Methotrexate—ankylosing spondylitis	0.000415	0.00286	CcSEcCtD
Rivaroxaban—Shock—Triamcinolone—ankylosing spondylitis	0.000414	0.00285	CcSEcCtD
Rivaroxaban—Shock—Methylprednisolone—ankylosing spondylitis	0.000413	0.00284	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000412	0.00284	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000411	0.00283	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000411	0.00283	CcSEcCtD
Rivaroxaban—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000411	0.00283	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—ankylosing spondylitis	0.000411	0.00283	CcSEcCtD
Rivaroxaban—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00041	0.00283	CcSEcCtD
Rivaroxaban—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000409	0.00282	CcSEcCtD
Rivaroxaban—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000407	0.00281	CcSEcCtD
Rivaroxaban—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000406	0.0028	CcSEcCtD
Rivaroxaban—Discomfort—Betamethasone—ankylosing spondylitis	0.000393	0.00271	CcSEcCtD
Rivaroxaban—Discomfort—Dexamethasone—ankylosing spondylitis	0.000393	0.00271	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000393	0.00271	CcSEcCtD
Rivaroxaban—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000392	0.0027	CcSEcCtD
Rivaroxaban—Pain—Prednisolone—ankylosing spondylitis	0.000391	0.00269	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000391	0.00269	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—ankylosing spondylitis	0.000391	0.00269	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000386	0.00266	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000383	0.00264	CcSEcCtD
Rivaroxaban—Oedema—Betamethasone—ankylosing spondylitis	0.000381	0.00263	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000381	0.00263	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000381	0.00263	CcSEcCtD
Rivaroxaban—Oedema—Dexamethasone—ankylosing spondylitis	0.000381	0.00263	CcSEcCtD
Rivaroxaban—Infection—Dexamethasone—ankylosing spondylitis	0.000379	0.00261	CcSEcCtD
Rivaroxaban—Infection—Betamethasone—ankylosing spondylitis	0.000379	0.00261	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000378	0.0026	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000377	0.0026	CcSEcCtD
Rivaroxaban—Anaemia—Prednisone—ankylosing spondylitis	0.000376	0.00259	CcSEcCtD
Rivaroxaban—Shock—Betamethasone—ankylosing spondylitis	0.000375	0.00259	CcSEcCtD
Rivaroxaban—Shock—Dexamethasone—ankylosing spondylitis	0.000375	0.00259	CcSEcCtD
Rivaroxaban—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000375	0.00258	CcSEcCtD
Rivaroxaban—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000374	0.00258	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000374	0.00258	CcSEcCtD
Rivaroxaban—Tachycardia—Betamethasone—ankylosing spondylitis	0.000372	0.00257	CcSEcCtD
Rivaroxaban—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000372	0.00257	CcSEcCtD
Rivaroxaban—Angioedema—Prednisone—ankylosing spondylitis	0.000372	0.00256	CcSEcCtD
Rivaroxaban—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00037	0.00255	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000369	0.00255	CcSEcCtD
Rivaroxaban—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000369	0.00254	CcSEcCtD
Rivaroxaban—Malaise—Prednisone—ankylosing spondylitis	0.000367	0.00253	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—ankylosing spondylitis	0.000365	0.00252	CcSEcCtD
Rivaroxaban—Syncope—Prednisone—ankylosing spondylitis	0.000365	0.00252	CcSEcCtD
Rivaroxaban—Urticaria—Prednisolone—ankylosing spondylitis	0.000363	0.0025	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000363	0.0025	CcSEcCtD
Rivaroxaban—Fatigue—Triamcinolone—ankylosing spondylitis	0.000362	0.0025	CcSEcCtD
Rivaroxaban—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000362	0.00249	CcSEcCtD
Rivaroxaban—Pain—Triamcinolone—ankylosing spondylitis	0.000359	0.00248	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000358	0.00246	CcSEcCtD
Rivaroxaban—Hypotension—Dexamethasone—ankylosing spondylitis	0.000356	0.00246	CcSEcCtD
Rivaroxaban—Hypotension—Betamethasone—ankylosing spondylitis	0.000356	0.00246	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—ankylosing spondylitis	0.000355	0.00244	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000353	0.00243	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000352	0.00243	CcSEcCtD
Rivaroxaban—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000346	0.00239	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000346	0.00238	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000344	0.00237	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000343	0.00236	CcSEcCtD
Rivaroxaban—Discomfort—Prednisone—ankylosing spondylitis	0.000342	0.00236	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000337	0.00232	CcSEcCtD
Rivaroxaban—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000336	0.00231	CcSEcCtD
Rivaroxaban—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000336	0.00231	CcSEcCtD
Rivaroxaban—Urticaria—Triamcinolone—ankylosing spondylitis	0.000334	0.0023	CcSEcCtD
Rivaroxaban—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000333	0.0023	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000332	0.00229	CcSEcCtD
Rivaroxaban—Oedema—Prednisone—ankylosing spondylitis	0.000332	0.00229	CcSEcCtD
Rivaroxaban—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000332	0.00228	CcSEcCtD
Rivaroxaban—Infection—Prednisone—ankylosing spondylitis	0.00033	0.00227	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000329	0.00227	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000329	0.00227	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—ankylosing spondylitis	0.000329	0.00227	CcSEcCtD
Rivaroxaban—Fatigue—Dexamethasone—ankylosing spondylitis	0.000329	0.00227	CcSEcCtD
Rivaroxaban—Fatigue—Betamethasone—ankylosing spondylitis	0.000329	0.00227	CcSEcCtD
Rivaroxaban—Shock—Prednisone—ankylosing spondylitis	0.000327	0.00225	CcSEcCtD
Rivaroxaban—Pain—Betamethasone—ankylosing spondylitis	0.000326	0.00225	CcSEcCtD
Rivaroxaban—Pain—Dexamethasone—ankylosing spondylitis	0.000326	0.00225	CcSEcCtD
Rivaroxaban—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000326	0.00224	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisone—ankylosing spondylitis	0.000324	0.00223	CcSEcCtD
Rivaroxaban—Skin disorder—Prednisone—ankylosing spondylitis	0.000323	0.00222	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000316	0.00217	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—ankylosing spondylitis	0.000314	0.00217	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000314	0.00217	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000314	0.00217	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000312	0.00215	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000312	0.00215	CcSEcCtD
Rivaroxaban—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00031	0.00213	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000309	0.00213	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—ankylosing spondylitis	0.000307	0.00211	CcSEcCtD
Rivaroxaban—Urticaria—Betamethasone—ankylosing spondylitis	0.000303	0.00209	CcSEcCtD
Rivaroxaban—Urticaria—Dexamethasone—ankylosing spondylitis	0.000303	0.00209	CcSEcCtD
Rivaroxaban—Dizziness—Prednisolone—ankylosing spondylitis	0.000302	0.00208	CcSEcCtD
Rivaroxaban—Asthenia—Triamcinolone—ankylosing spondylitis	0.000302	0.00208	CcSEcCtD
Rivaroxaban—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000302	0.00208	CcSEcCtD
Rivaroxaban—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000302	0.00208	CcSEcCtD
Rivaroxaban—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000301	0.00207	CcSEcCtD
Rivaroxaban—Pruritus—Triamcinolone—ankylosing spondylitis	0.000297	0.00205	CcSEcCtD
Rivaroxaban—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000297	0.00204	CcSEcCtD
Rivaroxaban—Dyspepsia—Prednisone—ankylosing spondylitis	0.000292	0.00201	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—ankylosing spondylitis	0.00029	0.002	CcSEcCtD
Rivaroxaban—Rash—Prednisolone—ankylosing spondylitis	0.000288	0.00199	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisolone—ankylosing spondylitis	0.000288	0.00198	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000288	0.00198	CcSEcCtD
Rivaroxaban—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000287	0.00198	CcSEcCtD
Rivaroxaban—Fatigue—Prednisone—ankylosing spondylitis	0.000286	0.00197	CcSEcCtD
Rivaroxaban—Headache—Prednisolone—ankylosing spondylitis	0.000286	0.00197	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—ankylosing spondylitis	0.000286	0.00197	CcSEcCtD
Rivaroxaban—Constipation—Prednisone—ankylosing spondylitis	0.000284	0.00196	CcSEcCtD
Rivaroxaban—Dizziness—Triamcinolone—ankylosing spondylitis	0.000278	0.00192	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000278	0.00191	CcSEcCtD
Rivaroxaban—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000277	0.00191	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—ankylosing spondylitis	0.000276	0.0019	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000274	0.00189	CcSEcCtD
Rivaroxaban—Asthenia—Dexamethasone—ankylosing spondylitis	0.000274	0.00189	CcSEcCtD
Rivaroxaban—Asthenia—Betamethasone—ankylosing spondylitis	0.000274	0.00189	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000272	0.00188	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000272	0.00187	CcSEcCtD
Rivaroxaban—Nausea—Prednisolone—ankylosing spondylitis	0.000272	0.00187	CcSEcCtD
Rivaroxaban—Pruritus—Betamethasone—ankylosing spondylitis	0.00027	0.00186	CcSEcCtD
Rivaroxaban—Pruritus—Dexamethasone—ankylosing spondylitis	0.00027	0.00186	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—ankylosing spondylitis	0.00027	0.00186	CcSEcCtD
Rivaroxaban—Vomiting—Triamcinolone—ankylosing spondylitis	0.000267	0.00184	CcSEcCtD
Rivaroxaban—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000267	0.00184	CcSEcCtD
Rivaroxaban—Rash—Triamcinolone—ankylosing spondylitis	0.000265	0.00183	CcSEcCtD
Rivaroxaban—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000265	0.00182	CcSEcCtD
Rivaroxaban—Rash—Methylprednisolone—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Rivaroxaban—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Rivaroxaban—Urticaria—Prednisone—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Rivaroxaban—Headache—Triamcinolone—ankylosing spondylitis	0.000263	0.00181	CcSEcCtD
Rivaroxaban—Headache—Methylprednisolone—ankylosing spondylitis	0.000263	0.00181	CcSEcCtD
Rivaroxaban—Abdominal pain—Prednisone—ankylosing spondylitis	0.000263	0.00181	CcSEcCtD
Rivaroxaban—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000261	0.0018	CcSEcCtD
Rivaroxaban—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000261	0.0018	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—ankylosing spondylitis	0.000259	0.00179	CcSEcCtD
Rivaroxaban—Dizziness—Dexamethasone—ankylosing spondylitis	0.000252	0.00174	CcSEcCtD
Rivaroxaban—Dizziness—Betamethasone—ankylosing spondylitis	0.000252	0.00174	CcSEcCtD
Rivaroxaban—Nausea—Triamcinolone—ankylosing spondylitis	0.00025	0.00172	CcSEcCtD
Rivaroxaban—Nausea—Methylprednisolone—ankylosing spondylitis	0.000249	0.00172	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000247	0.00171	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000245	0.00169	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000244	0.00168	CcSEcCtD
Rivaroxaban—Vomiting—Dexamethasone—ankylosing spondylitis	0.000243	0.00167	CcSEcCtD
Rivaroxaban—Vomiting—Betamethasone—ankylosing spondylitis	0.000243	0.00167	CcSEcCtD
Rivaroxaban—Rash—Betamethasone—ankylosing spondylitis	0.00024	0.00166	CcSEcCtD
Rivaroxaban—Rash—Dexamethasone—ankylosing spondylitis	0.00024	0.00166	CcSEcCtD
Rivaroxaban—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00024	0.00166	CcSEcCtD
Rivaroxaban—Dermatitis—Betamethasone—ankylosing spondylitis	0.00024	0.00166	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00165	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Rivaroxaban—Headache—Betamethasone—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Rivaroxaban—Headache—Dexamethasone—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Rivaroxaban—Asthenia—Prednisone—ankylosing spondylitis	0.000238	0.00164	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—ankylosing spondylitis	0.000237	0.00164	CcSEcCtD
Rivaroxaban—Pruritus—Prednisone—ankylosing spondylitis	0.000235	0.00162	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000229	0.00158	CcSEcCtD
Rivaroxaban—Diarrhoea—Prednisone—ankylosing spondylitis	0.000227	0.00157	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000227	0.00156	CcSEcCtD
Rivaroxaban—Nausea—Dexamethasone—ankylosing spondylitis	0.000227	0.00156	CcSEcCtD
Rivaroxaban—Nausea—Betamethasone—ankylosing spondylitis	0.000227	0.00156	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—ankylosing spondylitis	0.000221	0.00152	CcSEcCtD
Rivaroxaban—Dizziness—Prednisone—ankylosing spondylitis	0.00022	0.00151	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000219	0.00151	CcSEcCtD
Rivaroxaban—Vomiting—Prednisone—ankylosing spondylitis	0.000211	0.00146	CcSEcCtD
Rivaroxaban—Rash—Prednisone—ankylosing spondylitis	0.000209	0.00144	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisone—ankylosing spondylitis	0.000209	0.00144	CcSEcCtD
Rivaroxaban—Headache—Prednisone—ankylosing spondylitis	0.000208	0.00143	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000205	0.00141	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—ankylosing spondylitis	0.000199	0.00137	CcSEcCtD
Rivaroxaban—Nausea—Prednisone—ankylosing spondylitis	0.000197	0.00136	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—ankylosing spondylitis	0.000196	0.00135	CcSEcCtD
Rivaroxaban—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Rivaroxaban—Dizziness—Methotrexate—ankylosing spondylitis	0.000184	0.00126	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—ankylosing spondylitis	0.000177	0.00122	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—ankylosing spondylitis	0.000175	0.00121	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—ankylosing spondylitis	0.000175	0.00121	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—ankylosing spondylitis	0.000165	0.00114	CcSEcCtD
